news-09072024-115738

Cori Lint, a software engineer and part-time cellist, was often happy, but experienced sudden mood swings, panic attacks, and suicidal thoughts a few days every month. Despite being diagnosed with anxiety and depression, Lint struggled to understand her symptoms until she realized they were cyclical and linked to her menstrual cycle in 2022.

Premenstrual dysphoric disorder (PMDD) is a severe negative reaction to hormonal changes before a menstrual period, causing symptoms like irritability, anxiety, depression, and mood swings. Unlike premenstrual syndrome (PMS), PMDD symptoms can be life-altering and affect around 5% of people who menstruate. However, the disorder remains relatively unknown among healthcare providers.

Many women with PMDD face misdiagnosis or dismissal of their symptoms. Jenna Tingum, a premed student, only discovered her PMDD after her girlfriend noticed her symptoms flared up before her period. Suicide risk is high among PMDD patients, with 72% reporting suicidal thoughts and 34% attempting suicide.

Treatment options for PMDD include selective serotonin reuptake inhibitors, hormonal birth control, and talk therapy. Despite limited research and funding, organizations like the International Association for Premenstrual Disorders offer support for patients. The recent White House initiative on advancing women’s health research aims to address gaps in understanding PMDD.

Lint and Tingum emphasized the importance of discussing periods openly to avoid delayed diagnosis and care. Understanding their cycles helped them manage their condition better. Lint finds comfort in knowing she’s not alone in dealing with PMDD and that her experiences are valid.

Overall, PMDD is a complex disorder that requires more research, awareness, and support for those affected. By shedding light on the impact of menstruation on mental health, we can improve diagnosis, treatment, and quality of life for individuals with PMDD.